Study of VELCADE and Rituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma
Public ClinicalTrials.gov record NCT00312845. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Open-Label, Multicenter Study of VELCADE With Rituximab or Rituximab Alone in Subjects With Relapsed or Refractory, Rituximab Naive or Sensitive Follicular B-cell Non-Hodgkin's Lymphoma
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine if the combination of VELCADE and rituximab improves progression free survival relative to rituximab alone in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma (B-NHL) who never received rituximab or who have previously responded to rituximab. This is an international study being conducted in the United States and in many countries around the world. A complete list of study locations is listed below.
Study identification
- NCT ID
- NCT00312845
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 676 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 2006 (Type not available)
- Primary completion
- Jun 2010 (Actual)
- Completion
- Jul 2010 (Actual)
- Last update posted
- Jun 25, 2012
2006 – 2010
United States locations
- U.S. sites
- 41
- U.S. states
- 20
- U.S. cities
- 39
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| East Alabama Medical Center | Opelika | Alabama | — | — |
| Central Hematology Oncology Medical Group, Inc | Alhambra | California | 91801 | — |
| Comprehensive Blood and Cancer Center | Bakersfield | California | 93309 | — |
| Providence Saint Joseph Medical Center | Burbank | California | 91505 | — |
| St. Jude Heritage Medical Group | Fullerton | California | 92835 | — |
| Wilshire Oncology Medical Group, Inc. | La Verne | California | 91790 | — |
| Pacific Shores Medical Group | Long Beach | California | 90813 | — |
| University of Southern California | Los Angeles | California | 90033 | — |
| University of California, Los Angeles | Los Angeles | California | 90095 | — |
| North Valley Hematology Oncology | Mission Hills | California | 91345 | — |
| University of California, Irvine Medical Center | Orange | California | 92868 | — |
| Ventura County Hematology-Oncology Specialists | Oxnard | California | 93030 | — |
| Cancer Care Associates Medical Group, Inc. | Redondo Beach | California | 90277 | — |
| Central Coast Medical Oncology Corporation | Santa Maria | California | 93454 | — |
| Norwalk Medical Group | Norwalk | Connecticut | — | — |
| Hematology Oncology PC | Stamford | Connecticut | — | — |
| Integrated Community Oncology Network | Jacksonville | Florida | — | — |
| Innovative Clinical Research of South Florida | Miami | Florida | — | — |
| Palm Beach Cancer Institute | West Palm Beach | Florida | — | — |
| Emory Univeersity ,Winship Cancer Institute | Atlanta | Georgia | — | — |
| Suburban Hematology-Oncology Associates | Lawrenceville | Georgia | 30045 | — |
| Northwest Georgia Oncology Centers, P.C. | Marietta | Georgia | 30060 | — |
| North Idaho Cancer Center | Coeur d'Alene | Idaho | — | — |
| Investigative Clinical Research of Indiana | Indianapolis | Indiana | — | — |
| Siouxland Hematolgoy-Oncology Associates | Sioux City | Iowa | — | — |
| Kansas City Cancer Center, LLC | Kansas City | Kansas | 66210 | — |
| Louisville Oncology | Louisville | Kentucky | — | — |
| Hematology & Oncology Specialists | Metairie | Louisiana | — | — |
| Sinai Hospital | Baltimore | Maryland | — | — |
| Hattiesburg Clinic | Hattesburg | Missouri | — | — |
| Southeastern Medical Oncology Center | Goldsboro | North Carolina | 27530 | — |
| Oregon Health & Science University | Portland | Oregon | — | — |
| Lancaster Cancer Center, Ltd. | Lancaster | Pennsylvania | 17601 | — |
| The Western Pennsylvania Hospital | Pittsburgh | Pennsylvania | — | — |
| South Carolina Oncology Associates, PA | Columbia | South Carolina | 29210 | — |
| South Carolina Oncology Associates | Columbia | South Carolina | — | — |
| Vanderbilt University | Nashville | Tennessee | 37232 | — |
| The Center for Cancer and Blood Disorders | Fort Worth | Texas | — | — |
| Oncology Consultants | Houston | Texas | 777024 | — |
| South Texas Oncology and Hematology | San Antonio | Texas | — | — |
| Medical College of Wisconsin Milwaukee | Milwaukee | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 165 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00312845, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 25, 2012 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00312845 live on ClinicalTrials.gov.